Brian Canann

Bio

Mr. Canann has 15 years of operating and investing experience with healthcare companies. Prior to co-founding NaviMed Capital, he focused on venture and growth stage healthcare investments at The Carlyle Group since 2004. Previously, he led the global marketing effort for the Endeavor drug-eluting stent development program at Medtronic, the world’s largest medical technology company. His responsibilities included defining product requirements, providing marketing input into clinical strategy, prioritizing launch countries based on market potential, regulatory affairs and reimbursement status and planning an international investigator meeting for a 96-center, international clinical trial in collaboration with the clinical team. Mr. Canann held various strategic planning and global product management positions in the critical care division of Edwards Lifesciences, the global leader in heart valves and hemodynamic monitoring. His responsibilities focused primarily on global product management for central venous catheters, introducers and Swan-Ganz catheters. This division generated 50% of both revenues and profits from markets outside of the United States. He was also a CPA in the Boston office of Price Waterhouse. Mr. Canann is on the Board of Directors of Elenza. He is a Board Observer of AqueSys and PixelOptics. He previously served on the Board of Directors of Carefx (sold to Harris), the HealthCentral Network and Primary Health (sold to PacificSource Health Plans) and as a Board Observer of Endius (sold to Zimmer). Since 2008, Mr. Canann has served on the Cleveland Clinic Innovation Advisory Board, a select group of professional venture capitalists and seasoned entrepreneurs who advise the Cleveland Clinic on the commercial viability, investment decisions and funding strategies for new technologies and services and provide feedback on business plans. Mr. Canann holds an M.S. and a B.S. in accounting from Brigham Young University and an M.B.A. from Harvard Business School.

Career

---

NaviMed Capital Advisors LLC Managing Director Email: [email protected]